ReP USP - Resultado da busca

Artigo de periodico
Screening of medicines for malaria venture open boxes identifies potent SARS-CoV-2 papain-like protease (PLpro) inhibitors (2025)
Oliveira, Victor Gawriljuk Ferraro; Noske, Gabriela Dias ; Fernandes, Rafaela Sachetto ; Nakamura, Aline Minali ; Freire, Marjorie Caroline Liberato Cavalcanti ; Godoy, Mariana Ortiz de ; Bonatto, Vinícius ; Chelucci, Rafael Consolin ; Andricopulo, Adriano Defini ; Martins Júnior, Ronaldo Bragança ; Souza, Juliano de Paula ; Arruda, Eurico ; Guido, Rafael Victorio Carvalho ; Oliva, Glaucius ; Godoy, Andre Schutzer de
Source: ACS Omega. Unidades: IFSC, FCFRP, FMRP
Subjects: PROTEÍNAS, MALÁRIA, PLANEJAMENTO DE FÁRMACOS, COVID-19
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, Victor Gawriljuk Ferraro et al. Screening of medicines for malaria venture open boxes identifies potent SARS-CoV-2 papain-like protease (PLpro) inhibitors. ACS Omega, v. 10, n. 37, p. 42711-42724 + supporting information, 2025Tradução . . Disponível em: https://doi.org/10.1021/acsomega.5c04858. Acesso em: 07 out. 2025.
APA
Oliveira, V. G. F., Noske, G. D., Fernandes, R. S., Nakamura, A. M., Freire, M. C. L. C., Godoy, M. O. de, et al. (2025). Screening of medicines for malaria venture open boxes identifies potent SARS-CoV-2 papain-like protease (PLpro) inhibitors. ACS Omega, 10( 37), 42711-42724 + supporting information. doi:10.1021/acsomega.5c04858
NLM
Oliveira VGF, Noske GD, Fernandes RS, Nakamura AM, Freire MCLC, Godoy MO de, Bonatto V, Chelucci RC, Andricopulo AD, Martins Júnior RB, Souza J de P, Arruda E, Guido RVC, Oliva G, Godoy AS de. Screening of medicines for malaria venture open boxes identifies potent SARS-CoV-2 papain-like protease (PLpro) inhibitors [Internet]. ACS Omega. 2025 ; 10( 37): 42711-42724 + supporting information.[citado 2025 out. 07 ] Available from: https://doi.org/10.1021/acsomega.5c04858
Vancouver
Oliveira VGF, Noske GD, Fernandes RS, Nakamura AM, Freire MCLC, Godoy MO de, Bonatto V, Chelucci RC, Andricopulo AD, Martins Júnior RB, Souza J de P, Arruda E, Guido RVC, Oliva G, Godoy AS de. Screening of medicines for malaria venture open boxes identifies potent SARS-CoV-2 papain-like protease (PLpro) inhibitors [Internet]. ACS Omega. 2025 ; 10( 37): 42711-42724 + supporting information.[citado 2025 out. 07 ] Available from: https://doi.org/10.1021/acsomega.5c04858
Artigo de periodico
An in-solution snapshot of SARS-COV-2main protease maturation process and inhibition (2023)
Noske, Gabriela Dias; Song, Yun; Fernandes, Rafaela Sachetto ; Chalk, Rod; Elmassoudi, Haitem; Koekemoer, Lizbé; Owen, Christopher David ; El-Baba, Tarick John; Robinson, Dame Carol ; Oliva, Glaucius ; Godoy, Andre Schutzer de
Source: Nature Communications. Unidade: IFSC
Subjects: COVID-19, ENZIMAS, ESPECTROSCOPIA, PROTEÍNAS, PLANEJAMENTO DE FÁRMACOS, MICROSCOPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NOSKE, Gabriela Dias et al. An in-solution snapshot of SARS-COV-2main protease maturation process and inhibition. Nature Communications, v. 14, p. 1545-1-1545-13 + supplementary information, 2023Tradução . . Disponível em: https://doi.org/10.1038/s41467-023-37035-5. Acesso em: 07 out. 2025.
APA
Noske, G. D., Song, Y., Fernandes, R. S., Chalk, R., Elmassoudi, H., Koekemoer, L., et al. (2023). An in-solution snapshot of SARS-COV-2main protease maturation process and inhibition. Nature Communications, 14, 1545-1-1545-13 + supplementary information. doi:10.1038/s41467-023-37035-5
NLM
Noske GD, Song Y, Fernandes RS, Chalk R, Elmassoudi H, Koekemoer L, Owen CD, El-Baba TJ, Robinson DC, Oliva G, Godoy AS de. An in-solution snapshot of SARS-COV-2main protease maturation process and inhibition [Internet]. Nature Communications. 2023 ; 14 1545-1-1545-13 + supplementary information.[citado 2025 out. 07 ] Available from: https://doi.org/10.1038/s41467-023-37035-5
Vancouver
Noske GD, Song Y, Fernandes RS, Chalk R, Elmassoudi H, Koekemoer L, Owen CD, El-Baba TJ, Robinson DC, Oliva G, Godoy AS de. An in-solution snapshot of SARS-COV-2main protease maturation process and inhibition [Internet]. Nature Communications. 2023 ; 14 1545-1-1545-13 + supplementary information.[citado 2025 out. 07 ] Available from: https://doi.org/10.1038/s41467-023-37035-5
Artigo de periodico
Discovery of PLpro and Mpro Inhibitors for SARS-CoV-2 (2023)
Puhl, Ana Cristina ; Godoy, Andre Schutzer de ; Noske, Gabriela Dias; Nakamura, Aline Minali; Gawriljuk, Victor Oliveira; Fernandes, Rafaela Sachetto ; Oliva, Glaucius ; Ekins, Sean
Source: ACS Omega. Unidade: IFSC
Subjects: COVID-19, PEPTÍDEOS, AGENTES ANTIMICROBIANOS, PLANEJAMENTO DE FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PUHL, Ana Cristina et al. Discovery of PLpro and Mpro Inhibitors for SARS-CoV-2. ACS Omega, v. 8, n. 25, p. 22603-22612, 2023Tradução . . Disponível em: https://doi.org/10.1021/acsomega.3c01110. Acesso em: 07 out. 2025.
APA
Puhl, A. C., Godoy, A. S. de, Noske, G. D., Nakamura, A. M., Gawriljuk, V. O., Fernandes, R. S., et al. (2023). Discovery of PLpro and Mpro Inhibitors for SARS-CoV-2. ACS Omega, 8( 25), 22603-22612. doi:10.1021/acsomega.3c01110
NLM
Puhl AC, Godoy AS de, Noske GD, Nakamura AM, Gawriljuk VO, Fernandes RS, Oliva G, Ekins S. Discovery of PLpro and Mpro Inhibitors for SARS-CoV-2 [Internet]. ACS Omega. 2023 ; 8( 25): 22603-22612.[citado 2025 out. 07 ] Available from: https://doi.org/10.1021/acsomega.3c01110
Vancouver
Puhl AC, Godoy AS de, Noske GD, Nakamura AM, Gawriljuk VO, Fernandes RS, Oliva G, Ekins S. Discovery of PLpro and Mpro Inhibitors for SARS-CoV-2 [Internet]. ACS Omega. 2023 ; 8( 25): 22603-22612.[citado 2025 out. 07 ] Available from: https://doi.org/10.1021/acsomega.3c01110
Artigo de jornal-dep/entr
Revelados novos detalhes do processo de maturação da proteína-chave para a replicação do SARS-CoV-2. [Depoimento] (2023)
Westfahl Junior, Harry; Godoy, Andre Schutzer de ; Noske, Gabriela Dias
Source: Agência FAPESP. Unidade: IFSC
Subjects: COVID-19, ENZIMAS, PESQUISA CIENTÍFICA, ESPECTROSCOPIA, PLANEJAMENTO DE FÁRMACOS, PROTEÍNAS, MICROSCOPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WESTFAHL JUNIOR, Harry e GODOY, Andre Schutzer de e NOSKE, Gabriela Dias. Revelados novos detalhes do processo de maturação da proteína-chave para a replicação do SARS-CoV-2. [Depoimento]. Agência FAPESP. São Paulo: Instituto de Física de São Carlos, Universidade de São Paulo. Disponível em: https://agencia.fapesp.br/revelados-novos-detalhes-do-processo-de-maturacao-da-proteina-chave-para-a-replicacao-do-sars-cov-2/41468/. Acesso em: 07 out. 2025. , 2023
APA
Westfahl Junior, H., Godoy, A. S. de, & Noske, G. D. (2023). Revelados novos detalhes do processo de maturação da proteína-chave para a replicação do SARS-CoV-2. [Depoimento]. Agência FAPESP. São Paulo: Instituto de Física de São Carlos, Universidade de São Paulo. Recuperado de https://agencia.fapesp.br/revelados-novos-detalhes-do-processo-de-maturacao-da-proteina-chave-para-a-replicacao-do-sars-cov-2/41468/
NLM
Westfahl Junior H, Godoy AS de, Noske GD. Revelados novos detalhes do processo de maturação da proteína-chave para a replicação do SARS-CoV-2. [Depoimento] [Internet]. Agência FAPESP. 2023 ;[citado 2025 out. 07 ] Available from: https://agencia.fapesp.br/revelados-novos-detalhes-do-processo-de-maturacao-da-proteina-chave-para-a-replicacao-do-sars-cov-2/41468/
Vancouver
Westfahl Junior H, Godoy AS de, Noske GD. Revelados novos detalhes do processo de maturação da proteína-chave para a replicação do SARS-CoV-2. [Depoimento] [Internet]. Agência FAPESP. 2023 ;[citado 2025 out. 07 ] Available from: https://agencia.fapesp.br/revelados-novos-detalhes-do-processo-de-maturacao-da-proteina-chave-para-a-replicacao-do-sars-cov-2/41468/
Artigo de periodico
Imidazonaphthyridine effects on Chikungunya virus replication: antiviral activity by dependent and independent of interferon type 1 pathways (2023)
Ruiz, Uriel Enrique Aquino; Santos, Igor de Andrade; Grosche, Victória Riquena; Fernandes, Rafaela Sachetto ; Godoy, Andre Schutzer de ; Torres, Jhoan David Aguillón; Freire, Marjorie Caroline Liberato Cavalcanti ; Mesquita, Nathalya Cristina de Moraes Roso; Vega, Marco Fidel Guevara; Nicolau Junior, Nilson; Silva, Robinson Sabino da ; Mineo, Tiago Wilson Patriarca; Oliva, Glaucius ; Jardim, Ana Carolina Gomes
Source: Virus Research. Unidade: IFSC
Subjects: VÍRUS CHIKUNGUNYA, ANTIVIRAIS, PLANEJAMENTO DE FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RUIZ, Uriel Enrique Aquino et al. Imidazonaphthyridine effects on Chikungunya virus replication: antiviral activity by dependent and independent of interferon type 1 pathways. Virus Research, v. 324, n. Ja 2023, p. 199029-1-199029-14 + supplementary materials, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.virusres.2022.199029. Acesso em: 07 out. 2025.
APA
Ruiz, U. E. A., Santos, I. de A., Grosche, V. R., Fernandes, R. S., Godoy, A. S. de, Torres, J. D. A., et al. (2023). Imidazonaphthyridine effects on Chikungunya virus replication: antiviral activity by dependent and independent of interferon type 1 pathways. Virus Research, 324( Ja 2023), 199029-1-199029-14 + supplementary materials. doi:10.1016/j.virusres.2022.199029
NLM
Ruiz UEA, Santos I de A, Grosche VR, Fernandes RS, Godoy AS de, Torres JDA, Freire MCLC, Mesquita NC de MR, Vega MFG, Nicolau Junior N, Silva RS da, Mineo TWP, Oliva G, Jardim ACG. Imidazonaphthyridine effects on Chikungunya virus replication: antiviral activity by dependent and independent of interferon type 1 pathways [Internet]. Virus Research. 2023 ; 324( Ja 2023): 199029-1-199029-14 + supplementary materials.[citado 2025 out. 07 ] Available from: https://doi.org/10.1016/j.virusres.2022.199029
Vancouver
Ruiz UEA, Santos I de A, Grosche VR, Fernandes RS, Godoy AS de, Torres JDA, Freire MCLC, Mesquita NC de MR, Vega MFG, Nicolau Junior N, Silva RS da, Mineo TWP, Oliva G, Jardim ACG. Imidazonaphthyridine effects on Chikungunya virus replication: antiviral activity by dependent and independent of interferon type 1 pathways [Internet]. Virus Research. 2023 ; 324( Ja 2023): 199029-1-199029-14 + supplementary materials.[citado 2025 out. 07 ] Available from: https://doi.org/10.1016/j.virusres.2022.199029
Artigo de periodico
Amino acid polymorphisms on the Brazilian strain of yellow fever virus methyltransferase are related to the host’s immune evasion mediated by type I interferon (2023)
Furtado, Nathália Dias ; Mello, Iasmim Silva de; Godoy, Andre Schutzer de ; Noske, Gabriela Dias; Oliva, Glaucius ; Canard, Bruno; Decroly, Etienne ; Bonaldo, Myrna Cristina
Source: Viruses. Unidade: IFSC
Subjects: FEBRE AMARELA, FLAVIVIRUS, POLIMORFISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FURTADO, Nathália Dias et al. Amino acid polymorphisms on the Brazilian strain of yellow fever virus methyltransferase are related to the host’s immune evasion mediated by type I interferon. Viruses, v. 15, n. Ja 2023, p. 191-1-191-18 + supplementary materials, 2023Tradução . . Disponível em: https://doi.org/10.3390/v15010191. Acesso em: 07 out. 2025.
APA
Furtado, N. D., Mello, I. S. de, Godoy, A. S. de, Noske, G. D., Oliva, G., Canard, B., et al. (2023). Amino acid polymorphisms on the Brazilian strain of yellow fever virus methyltransferase are related to the host’s immune evasion mediated by type I interferon. Viruses, 15( Ja 2023), 191-1-191-18 + supplementary materials. doi:10.3390/v15010191
NLM
Furtado ND, Mello IS de, Godoy AS de, Noske GD, Oliva G, Canard B, Decroly E, Bonaldo MC. Amino acid polymorphisms on the Brazilian strain of yellow fever virus methyltransferase are related to the host’s immune evasion mediated by type I interferon [Internet]. Viruses. 2023 ; 15( Ja 2023): 191-1-191-18 + supplementary materials.[citado 2025 out. 07 ] Available from: https://doi.org/10.3390/v15010191
Vancouver
Furtado ND, Mello IS de, Godoy AS de, Noske GD, Oliva G, Canard B, Decroly E, Bonaldo MC. Amino acid polymorphisms on the Brazilian strain of yellow fever virus methyltransferase are related to the host’s immune evasion mediated by type I interferon [Internet]. Viruses. 2023 ; 15( Ja 2023): 191-1-191-18 + supplementary materials.[citado 2025 out. 07 ] Available from: https://doi.org/10.3390/v15010191
Artigo de periodico
Structural basis of nirmatrelvir and ensitrelvir activity against naturally occurring polymorphisms of the SARS-CoV-2 main protease (2023)
Noske, Gabriela Dias; Silva, Ellen de Souza; Godoy, Mariana Ortiz de ; Dolci, Isabela ; Fernandes, Rafaela Sachetto ; Guido, Rafael Victorio Carvalho ; Sjo, Peter ; Oliva, Glaucius ; Godoy, Andre Schutzer de
Source: Journal of Biological Chemistry. Unidade: IFSC
Subjects: COVID-19, CORONAVIRUS, RESISTÊNCIA MICROBIANA ÀS DROGAS, MUTAÇÃO GENÉTICA, RAIOS X, ANTIVIRAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NOSKE, Gabriela Dias et al. Structural basis of nirmatrelvir and ensitrelvir activity against naturally occurring polymorphisms of the SARS-CoV-2 main protease. Journal of Biological Chemistry, v. 299, n. 3, p. 103004-1-103004-10 + supporting information: 1-3, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.jbc.2023.103004. Acesso em: 07 out. 2025.
APA
Noske, G. D., Silva, E. de S., Godoy, M. O. de, Dolci, I., Fernandes, R. S., Guido, R. V. C., et al. (2023). Structural basis of nirmatrelvir and ensitrelvir activity against naturally occurring polymorphisms of the SARS-CoV-2 main protease. Journal of Biological Chemistry, 299( 3), 103004-1-103004-10 + supporting information: 1-3. doi:10.1016/j.jbc.2023.103004
NLM
Noske GD, Silva E de S, Godoy MO de, Dolci I, Fernandes RS, Guido RVC, Sjo P, Oliva G, Godoy AS de. Structural basis of nirmatrelvir and ensitrelvir activity against naturally occurring polymorphisms of the SARS-CoV-2 main protease [Internet]. Journal of Biological Chemistry. 2023 ; 299( 3): 103004-1-103004-10 + supporting information: 1-3.[citado 2025 out. 07 ] Available from: https://doi.org/10.1016/j.jbc.2023.103004
Vancouver
Noske GD, Silva E de S, Godoy MO de, Dolci I, Fernandes RS, Guido RVC, Sjo P, Oliva G, Godoy AS de. Structural basis of nirmatrelvir and ensitrelvir activity against naturally occurring polymorphisms of the SARS-CoV-2 main protease [Internet]. Journal of Biological Chemistry. 2023 ; 299( 3): 103004-1-103004-10 + supporting information: 1-3.[citado 2025 out. 07 ] Available from: https://doi.org/10.1016/j.jbc.2023.103004
Artigo de periodico
Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitors (2023)
Boby, Melissa L.; Fernandes, Rafaela Sachetto ; Gawriljuk, Victor Oliveira; Godoy, Andre Schutzer de ; Nakamura, Aline Minali; Noske, Gabriela Dias; Oliva, Glaucius ; Rangel, Victor Lopes
Source: Science. Unidades: IFSC, FCFRP
Subjects: COVID-19, ENZIMAS, ESPECTROSCOPIA, PROTEÍNAS, PLANEJAMENTO DE FÁRMACOS, MICROSCOPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BOBY, Melissa L. et al. Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitors. Science, v. 382, n. 6671, p. eabo7201-1-eabo7201-16 + supplementary materials, 2023Tradução . . Disponível em: https://doi.org/10.1126/science.abo7201. Acesso em: 07 out. 2025.
APA
Boby, M. L., Fernandes, R. S., Gawriljuk, V. O., Godoy, A. S. de, Nakamura, A. M., Noske, G. D., et al. (2023). Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitors. Science, 382( 6671), eabo7201-1-eabo7201-16 + supplementary materials. doi:10.1126/science.abo7201
NLM
Boby ML, Fernandes RS, Gawriljuk VO, Godoy AS de, Nakamura AM, Noske GD, Oliva G, Rangel VL. Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitors [Internet]. Science. 2023 ; 382( 6671): eabo7201-1-eabo7201-16 + supplementary materials.[citado 2025 out. 07 ] Available from: https://doi.org/10.1126/science.abo7201
Vancouver
Boby ML, Fernandes RS, Gawriljuk VO, Godoy AS de, Nakamura AM, Noske GD, Oliva G, Rangel VL. Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitors [Internet]. Science. 2023 ; 382( 6671): eabo7201-1-eabo7201-16 + supplementary materials.[citado 2025 out. 07 ] Available from: https://doi.org/10.1126/science.abo7201
Artigo de periodico
Allosteric regulation and crystallographic fragment screening of SARS-CoV-2 NSP15 endoribonuclease (2023)
Godoy, Andre Schutzer de ; Nakamura, Aline Minali; Douangamath, Alice; Song, Yun; Noske, Gabriela Dias; Gawriljuk, Victor Oliveira; Fernandes, Rafaela Sachetto ; Pereira, Humberto d'Muniz ; Oliveira, Ketllyn Irene Zagato de; Fearon, Daren; Dias, Alexandre; Krojer, Tobias; Fairhead, Michael; Powell, Ailsa; Dunnet, Louise; Brandão Neto, José; Skyner, Rachael; Chalk, Rod; Bajusz, Dávid ; Bege, Miklós; Borbás, Anikó; Keseru, Gyorgy Miklós; von Delft, Frank ; Oliva, Glaucius
Source: Nucleic Acids Research. Unidade: IFSC
Subjects: CRISTALOGRAFIA DE RAIOS X, COVID-19, AGENTES ANTIMICROBIANOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GODOY, Andre Schutzer de et al. Allosteric regulation and crystallographic fragment screening of SARS-CoV-2 NSP15 endoribonuclease. Nucleic Acids Research, v. 51, n. 10, p. 5255-5270 + supplementary data, 2023Tradução . . Disponível em: https://doi.org/10.1093/nar/gkad314. Acesso em: 07 out. 2025.
APA
Godoy, A. S. de, Nakamura, A. M., Douangamath, A., Song, Y., Noske, G. D., Gawriljuk, V. O., et al. (2023). Allosteric regulation and crystallographic fragment screening of SARS-CoV-2 NSP15 endoribonuclease. Nucleic Acids Research, 51( 10), 5255-5270 + supplementary data. doi:10.1093/nar/gkad314
NLM
Godoy AS de, Nakamura AM, Douangamath A, Song Y, Noske GD, Gawriljuk VO, Fernandes RS, Pereira H d'M, Oliveira KIZ de, Fearon D, Dias A, Krojer T, Fairhead M, Powell A, Dunnet L, Brandão Neto J, Skyner R, Chalk R, Bajusz D, Bege M, Borbás A, Keseru GM, von Delft F, Oliva G. Allosteric regulation and crystallographic fragment screening of SARS-CoV-2 NSP15 endoribonuclease [Internet]. Nucleic Acids Research. 2023 ; 51( 10): 5255-5270 + supplementary data.[citado 2025 out. 07 ] Available from: https://doi.org/10.1093/nar/gkad314
Vancouver
Godoy AS de, Nakamura AM, Douangamath A, Song Y, Noske GD, Gawriljuk VO, Fernandes RS, Pereira H d'M, Oliveira KIZ de, Fearon D, Dias A, Krojer T, Fairhead M, Powell A, Dunnet L, Brandão Neto J, Skyner R, Chalk R, Bajusz D, Bege M, Borbás A, Keseru GM, von Delft F, Oliva G. Allosteric regulation and crystallographic fragment screening of SARS-CoV-2 NSP15 endoribonuclease [Internet]. Nucleic Acids Research. 2023 ; 51( 10): 5255-5270 + supplementary data.[citado 2025 out. 07 ] Available from: https://doi.org/10.1093/nar/gkad314
Artigo de periodico
Characterization of the RNA-dependent RNA polymerase from Chikungunya virus and discovery of a novel ligand as a potential drug candidate (2022)
Freire, Marjorie Caroline Liberato Cavalcanti ; Basso, Luís Guilherme Mansor; Mendes, Luís Felipe Santos ; Mesquita, Nathalya Cristina de Moraes Roso; Mottin, Melina; Fernandes, Rafaela Sachetto ; Policastro, Lucca Rocha ; Godoy, Andre Schutzer de ; Santos, Igor A. ; Ruiz, Uriel Enrique Aquino; Caruso, Icaro P.; Sousa, Bruna K. P.; Jardim, Ana C. G. ; Almeida, Fabio C. L.; Gil, Laura Helena Vega Gonzales; Andrade, Carolina H.; Oliva, Glaucius
Source: Scientific Reports. Unidades: IFSC, FFCLRP
Subjects: VÍRUS CHIKUNGUNYA, ESTRUTURA MOLECULAR (QUÍMICA TEÓRICA), QUÍMICA MÉDICA, RNA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FREIRE, Marjorie Caroline Liberato Cavalcanti et al. Characterization of the RNA-dependent RNA polymerase from Chikungunya virus and discovery of a novel ligand as a potential drug candidate. Scientific Reports, v. 12, p. 10601-1-10601-15, 2022Tradução . . Disponível em: https://doi.org/10.1038/s41598-022-14790-x. Acesso em: 07 out. 2025.
APA
Freire, M. C. L. C., Basso, L. G. M., Mendes, L. F. S., Mesquita, N. C. de M. R., Mottin, M., Fernandes, R. S., et al. (2022). Characterization of the RNA-dependent RNA polymerase from Chikungunya virus and discovery of a novel ligand as a potential drug candidate. Scientific Reports, 12, 10601-1-10601-15. doi:10.1038/s41598-022-14790-x
NLM
Freire MCLC, Basso LGM, Mendes LFS, Mesquita NC de MR, Mottin M, Fernandes RS, Policastro LR, Godoy AS de, Santos IA, Ruiz UEA, Caruso IP, Sousa BKP, Jardim ACG, Almeida FCL, Gil LHVG, Andrade CH, Oliva G. Characterization of the RNA-dependent RNA polymerase from Chikungunya virus and discovery of a novel ligand as a potential drug candidate [Internet]. Scientific Reports. 2022 ; 12 10601-1-10601-15.[citado 2025 out. 07 ] Available from: https://doi.org/10.1038/s41598-022-14790-x
Vancouver
Freire MCLC, Basso LGM, Mendes LFS, Mesquita NC de MR, Mottin M, Fernandes RS, Policastro LR, Godoy AS de, Santos IA, Ruiz UEA, Caruso IP, Sousa BKP, Jardim ACG, Almeida FCL, Gil LHVG, Andrade CH, Oliva G. Characterization of the RNA-dependent RNA polymerase from Chikungunya virus and discovery of a novel ligand as a potential drug candidate [Internet]. Scientific Reports. 2022 ; 12 10601-1-10601-15.[citado 2025 out. 07 ] Available from: https://doi.org/10.1038/s41598-022-14790-x
Artigo de periodico
The Antifungal itraconazole is a potent inhibitor of Chikungunya virus replication (2022)
Policastro, Lucca Rocha ; Dolci, Isabela; Godoy, Andre Schutzer de ; Silva Júnior, José V. J.; Ruiz, Uriel Enrique Aquino; Santos, Igor A. ; Jardim, Ana C. G. ; Samby, Kirandeep; Burrows, Jeremy N.; Wells, Timothy N. C.; Gil, Laura Helena Vega Gonzales; Oliva, Glaucius ; Fernandes, Rafaela Sachetto
Source: Viruses. Unidade: IFSC
Subjects: FEBRE AMARELA, FLAVIVIRUS, POLIMORFISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
POLICASTRO, Lucca Rocha et al. The Antifungal itraconazole is a potent inhibitor of Chikungunya virus replication. Viruses, v. 14, n. 7, p. 1351-1-1351-12, 2022Tradução . . Disponível em: https://doi.org/10.3390/v14071351. Acesso em: 07 out. 2025.
APA
Policastro, L. R., Dolci, I., Godoy, A. S. de, Silva Júnior, J. V. J., Ruiz, U. E. A., Santos, I. A., et al. (2022). The Antifungal itraconazole is a potent inhibitor of Chikungunya virus replication. Viruses, 14( 7), 1351-1-1351-12. doi:10.3390/v14071351
NLM
Policastro LR, Dolci I, Godoy AS de, Silva Júnior JVJ, Ruiz UEA, Santos IA, Jardim ACG, Samby K, Burrows JN, Wells TNC, Gil LHVG, Oliva G, Fernandes RS. The Antifungal itraconazole is a potent inhibitor of Chikungunya virus replication [Internet]. Viruses. 2022 ; 14( 7): 1351-1-1351-12.[citado 2025 out. 07 ] Available from: https://doi.org/10.3390/v14071351
Vancouver
Policastro LR, Dolci I, Godoy AS de, Silva Júnior JVJ, Ruiz UEA, Santos IA, Jardim ACG, Samby K, Burrows JN, Wells TNC, Gil LHVG, Oliva G, Fernandes RS. The Antifungal itraconazole is a potent inhibitor of Chikungunya virus replication [Internet]. Viruses. 2022 ; 14( 7): 1351-1-1351-12.[citado 2025 out. 07 ] Available from: https://doi.org/10.3390/v14071351
Artigo de periodico
Pyronaridine protects against SARS-CoV-2 infection in mouse (2022)
Puhl, Ana C. ; Gomes, Giovanni Freitas; Damasceno, Samara; Godoy, Andre Schutzer de ; Noske, Gabriela Dias; Nakamura, Aline Minali; Oliveira, Victor Gawriljuk Ferraro; Fernandes, Rafaela Sachetto ; Monakhova, Natalia; Riabova, Olga; Lane, Thomas R.; Makarov, Vadim; Veras, Flávio Protásio ; Batah, Sabrina Setembre ; Fabro, Alexandre Todorovic ; Oliva, Glaucius ; Cunha, Fernando de Queiroz ; Alves Filho, José Carlos Farias ; Cunha, Thiago Mattar ; Ekins, Sean
Source: ACS Infectious Diseases. Unidades: FMRP, IFSC
Subjects: COVID-19, IMUNOLOGIA, AGENTES ANTIMICROBIANOS, RESISTÊNCIA MICROBIANA ÀS DROGAS, VIRULÊNCIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PUHL, Ana C. et al. Pyronaridine protects against SARS-CoV-2 infection in mouse. ACS Infectious Diseases, v. 8, n. 6, p. 1147-1160, 2022Tradução . . Disponível em: https://doi.org/10.1021/acsinfecdis.2c00091. Acesso em: 07 out. 2025.
APA
Puhl, A. C., Gomes, G. F., Damasceno, S., Godoy, A. S. de, Noske, G. D., Nakamura, A. M., et al. (2022). Pyronaridine protects against SARS-CoV-2 infection in mouse. ACS Infectious Diseases, 8( 6), 1147-1160. doi:10.1021/acsinfecdis.2c00091
NLM
Puhl AC, Gomes GF, Damasceno S, Godoy AS de, Noske GD, Nakamura AM, Oliveira VGF, Fernandes RS, Monakhova N, Riabova O, Lane TR, Makarov V, Veras FP, Batah SS, Fabro AT, Oliva G, Cunha F de Q, Alves Filho JCF, Cunha TM, Ekins S. Pyronaridine protects against SARS-CoV-2 infection in mouse [Internet]. ACS Infectious Diseases. 2022 ; 8( 6): 1147-1160.[citado 2025 out. 07 ] Available from: https://doi.org/10.1021/acsinfecdis.2c00091
Vancouver
Puhl AC, Gomes GF, Damasceno S, Godoy AS de, Noske GD, Nakamura AM, Oliveira VGF, Fernandes RS, Monakhova N, Riabova O, Lane TR, Makarov V, Veras FP, Batah SS, Fabro AT, Oliva G, Cunha F de Q, Alves Filho JCF, Cunha TM, Ekins S. Pyronaridine protects against SARS-CoV-2 infection in mouse [Internet]. ACS Infectious Diseases. 2022 ; 8( 6): 1147-1160.[citado 2025 out. 07 ] Available from: https://doi.org/10.1021/acsinfecdis.2c00091
Artigo de periodico
Discovery of an imidazonaphthyridine and a riminophenazine as potent anti-Zika virus agents through a replicon-based high-throughput screening (2021)
Fernandes, Rafaela Sachetto; Godoy, Andre Schutzer; Santos, Igor Andrade; Noske, Gabriela Dias; Oliveira, Ketllyn Irene Zagato; Gawriljuk, Victor Oliveira; Jardim, Ana Carolina Gomes ; Oliva, Glaucius
Source: Virus Research. Unidade: IFSC
Subjects: ZIKA VÍRUS, PROTEÍNAS, FARMACOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERNANDES, Rafaela Sachetto et al. Discovery of an imidazonaphthyridine and a riminophenazine as potent anti-Zika virus agents through a replicon-based high-throughput screening. Virus Research, v. 299, p. 198388-1-198388-9, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.virusres.2021.198388. Acesso em: 07 out. 2025.
APA
Fernandes, R. S., Godoy, A. S., Santos, I. A., Noske, G. D., Oliveira, K. I. Z., Gawriljuk, V. O., et al. (2021). Discovery of an imidazonaphthyridine and a riminophenazine as potent anti-Zika virus agents through a replicon-based high-throughput screening. Virus Research, 299, 198388-1-198388-9. doi:10.1016/j.virusres.2021.198388
NLM
Fernandes RS, Godoy AS, Santos IA, Noske GD, Oliveira KIZ, Gawriljuk VO, Jardim ACG, Oliva G. Discovery of an imidazonaphthyridine and a riminophenazine as potent anti-Zika virus agents through a replicon-based high-throughput screening [Internet]. Virus Research. 2021 ; 299 198388-1-198388-9.[citado 2025 out. 07 ] Available from: https://doi.org/10.1016/j.virusres.2021.198388
Vancouver
Fernandes RS, Godoy AS, Santos IA, Noske GD, Oliveira KIZ, Gawriljuk VO, Jardim ACG, Oliva G. Discovery of an imidazonaphthyridine and a riminophenazine as potent anti-Zika virus agents through a replicon-based high-throughput screening [Internet]. Virus Research. 2021 ; 299 198388-1-198388-9.[citado 2025 out. 07 ] Available from: https://doi.org/10.1016/j.virusres.2021.198388
Artigo de periodico
A crystallographic snapshot of SARS-CoV-2 main protease maturation process (2021)
Noske, Gabriela Dias; Nakamura, Aline Minali; Oliveira, Victor Gawriljuk Ferraro; Fernandes, Rafaela Sachetto; Lima, G. M. A.; Rosa, Higor Vinicius Dias; Pereira, Humberto d'Muniz ; Zeri, A. C. M.; Nascimento, A. F. Z.; Freire, Marjorie Caroline Liberato Cavalcanti; Fearon, D.; Douangamath, A.; Delft, F. von; Oliva, Glaucius ; Godoy, Andre Schutzer de
Source: Journal of Molecular Biology. Unidade: IFSC
Subjects: CORONAVIRUS, ANTIVIRAIS, PROTEÍNAS, PLANEJAMENTO DE FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NOSKE, Gabriela Dias et al. A crystallographic snapshot of SARS-CoV-2 main protease maturation process. Journal of Molecular Biology, v. 433, n. 18, p. 167118-1-167118-16 + supplementary material, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.jmb.2021.167118. Acesso em: 07 out. 2025.
APA
Noske, G. D., Nakamura, A. M., Oliveira, V. G. F., Fernandes, R. S., Lima, G. M. A., Rosa, H. V. D., et al. (2021). A crystallographic snapshot of SARS-CoV-2 main protease maturation process. Journal of Molecular Biology, 433( 18), 167118-1-167118-16 + supplementary material. doi:10.1016/j.jmb.2021.167118
NLM
Noske GD, Nakamura AM, Oliveira VGF, Fernandes RS, Lima GMA, Rosa HVD, Pereira H d'M, Zeri ACM, Nascimento AFZ, Freire MCLC, Fearon D, Douangamath A, Delft F von, Oliva G, Godoy AS de. A crystallographic snapshot of SARS-CoV-2 main protease maturation process [Internet]. Journal of Molecular Biology. 2021 ; 433( 18): 167118-1-167118-16 + supplementary material.[citado 2025 out. 07 ] Available from: https://doi.org/10.1016/j.jmb.2021.167118
Vancouver
Noske GD, Nakamura AM, Oliveira VGF, Fernandes RS, Lima GMA, Rosa HVD, Pereira H d'M, Zeri ACM, Nascimento AFZ, Freire MCLC, Fearon D, Douangamath A, Delft F von, Oliva G, Godoy AS de. A crystallographic snapshot of SARS-CoV-2 main protease maturation process [Internet]. Journal of Molecular Biology. 2021 ; 433( 18): 167118-1-167118-16 + supplementary material.[citado 2025 out. 07 ] Available from: https://doi.org/10.1016/j.jmb.2021.167118
Trabalho de evento-resumo
Naphthyridine-derived compound effectively inhibits the early stages of CHIKV virus infection in vitro (2021)
Ruiz, Uriel Enrique Aquino; Santos, Igor de Andrade; Fernandes, Rafaela Sachetto ; Godoy, Andre Schutzer de ; Guevara-Vega, Marco; Nicolau Junior, Nilson; Silva, Robinson Sabino; Oliva, Glaucius ; Jardim, Ana Carolina Gomes
Source: Anais. Conference titles: Congresso Brasileiro de Virologia - CBV: Virologia em Casa. Unidade: IFSC
Subjects: ANTIVIRAIS, VÍRUS CHIKUNGUNYA, CULTURA DE CÉLULAS, PLANEJAMENTO DE FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RUIZ, Uriel Enrique Aquino et al. Naphthyridine-derived compound effectively inhibits the early stages of CHIKV virus infection in vitro. 2021, Anais.. Belo Horizonte: Even3, 2021. Disponível em: https://www.even3.com.br/anais/cbv2021/410853-naphthyridine-derived-compound-effectively-inhibits-the-early-stages-of-chikv-virus-infection-in-/. Acesso em: 07 out. 2025.
APA
Ruiz, U. E. A., Santos, I. de A., Fernandes, R. S., Godoy, A. S. de, Guevara-Vega, M., Nicolau Junior, N., et al. (2021). Naphthyridine-derived compound effectively inhibits the early stages of CHIKV virus infection in vitro. In Anais. Belo Horizonte: Even3. Recuperado de https://www.even3.com.br/anais/cbv2021/410853-naphthyridine-derived-compound-effectively-inhibits-the-early-stages-of-chikv-virus-infection-in-/
NLM
Ruiz UEA, Santos I de A, Fernandes RS, Godoy AS de, Guevara-Vega M, Nicolau Junior N, Silva RS, Oliva G, Jardim ACG. Naphthyridine-derived compound effectively inhibits the early stages of CHIKV virus infection in vitro [Internet]. Anais. 2021 ;[citado 2025 out. 07 ] Available from: https://www.even3.com.br/anais/cbv2021/410853-naphthyridine-derived-compound-effectively-inhibits-the-early-stages-of-chikv-virus-infection-in-/
Vancouver
Ruiz UEA, Santos I de A, Fernandes RS, Godoy AS de, Guevara-Vega M, Nicolau Junior N, Silva RS, Oliva G, Jardim ACG. Naphthyridine-derived compound effectively inhibits the early stages of CHIKV virus infection in vitro [Internet]. Anais. 2021 ;[citado 2025 out. 07 ] Available from: https://www.even3.com.br/anais/cbv2021/410853-naphthyridine-derived-compound-effectively-inhibits-the-early-stages-of-chikv-virus-infection-in-/
Artigo de periodico
Non-Toxic dimeric peptides derived from the bothropstoxin-I are potent SARS-CoV-2 and papain-like protease inhibitors (2021)
Freire, Marjorie Caroline Liberato Cavalcanti ; Noske, Gabriela Dias; Bitencourt, Natália Vitória ; Sanches, Paulo R. S.; Santos-Filho, Norival A.; Oliveira, Victor Gawriljuk Ferraro; Souza, Eduardo Pereira de ; Nogueira, Victor Henrique Rabesquine ; Godoy, Mariana Ortiz de; Nakamura, Aline Minali; Fernandes, Rafaela Sachetto ; Godoy, Andre Schutzer de ; Juliano, Maria A.; Peres, Bianca de Miranda ; Barbosa, Cecília G.; Moraes, Carolina Borsoi ; Freitas Junior, Lucio Holanda Gondim de ; Cilli, Eduardo Maffud ; Guido, Rafael Victorio Carvalho ; Oliva, Glaucius
Source: Molecules. Unidades: IFSC, ICB
Subjects: COVID-19, CORONAVIRUS, PLANEJAMENTO DE FÁRMACOS, PROTEÍNAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FREIRE, Marjorie Caroline Liberato Cavalcanti et al. Non-Toxic dimeric peptides derived from the bothropstoxin-I are potent SARS-CoV-2 and papain-like protease inhibitors. Molecules, v. 26, n. 16, p. 4896-1-4896-17, 2021Tradução . . Disponível em: https://doi.org/10.3390/molecules26164896. Acesso em: 07 out. 2025.
APA
Freire, M. C. L. C., Noske, G. D., Bitencourt, N. V., Sanches, P. R. S., Santos-Filho, N. A., Oliveira, V. G. F., et al. (2021). Non-Toxic dimeric peptides derived from the bothropstoxin-I are potent SARS-CoV-2 and papain-like protease inhibitors. Molecules, 26( 16), 4896-1-4896-17. doi:10.3390/molecules26164896
NLM
Freire MCLC, Noske GD, Bitencourt NV, Sanches PRS, Santos-Filho NA, Oliveira VGF, Souza EP de, Nogueira VHR, Godoy MO de, Nakamura AM, Fernandes RS, Godoy AS de, Juliano MA, Peres B de M, Barbosa CG, Moraes CB, Freitas Junior LHG de, Cilli EM, Guido RVC, Oliva G. Non-Toxic dimeric peptides derived from the bothropstoxin-I are potent SARS-CoV-2 and papain-like protease inhibitors [Internet]. Molecules. 2021 ; 26( 16): 4896-1-4896-17.[citado 2025 out. 07 ] Available from: https://doi.org/10.3390/molecules26164896
Vancouver
Freire MCLC, Noske GD, Bitencourt NV, Sanches PRS, Santos-Filho NA, Oliveira VGF, Souza EP de, Nogueira VHR, Godoy MO de, Nakamura AM, Fernandes RS, Godoy AS de, Juliano MA, Peres B de M, Barbosa CG, Moraes CB, Freitas Junior LHG de, Cilli EM, Guido RVC, Oliva G. Non-Toxic dimeric peptides derived from the bothropstoxin-I are potent SARS-CoV-2 and papain-like protease inhibitors [Internet]. Molecules. 2021 ; 26( 16): 4896-1-4896-17.[citado 2025 out. 07 ] Available from: https://doi.org/10.3390/molecules26164896
Artigo de periodico
High-throughput antiviral assays to screen for inhibitors of Zika virus replication (2021)
Fernandes, Rafaela Sachetto ; Noske, Gabriela Dias; Gawriljuk, Victor Oliveira; Oliveira, Ketllyn Irene Zagato; Godoy, Andre Schutzer; Mesquita, Nathalya Cristina de Moraes Roso; Oliva, Glaucius
Source: Journal of Visualized Experiments - JOVE. Unidade: IFSC
Subjects: ZIKA VÍRUS, FLAVIVIRUS, FARMACOLOGIA, PLANEJAMENTO DE FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERNANDES, Rafaela Sachetto et al. High-throughput antiviral assays to screen for inhibitors of Zika virus replication. Journal of Visualized Experiments - JOVE, v. 176, p. e62422-1-e62422-11, 2021Tradução . . Disponível em: https://doi.org/10.3791/62422. Acesso em: 07 out. 2025.
APA
Fernandes, R. S., Noske, G. D., Gawriljuk, V. O., Oliveira, K. I. Z., Godoy, A. S., Mesquita, N. C. de M. R., & Oliva, G. (2021). High-throughput antiviral assays to screen for inhibitors of Zika virus replication. Journal of Visualized Experiments - JOVE, 176, e62422-1-e62422-11. doi:10.3791/62422
NLM
Fernandes RS, Noske GD, Gawriljuk VO, Oliveira KIZ, Godoy AS, Mesquita NC de MR, Oliva G. High-throughput antiviral assays to screen for inhibitors of Zika virus replication [Internet]. Journal of Visualized Experiments - JOVE. 2021 ; 176 e62422-1-e62422-11.[citado 2025 out. 07 ] Available from: https://doi.org/10.3791/62422
Vancouver
Fernandes RS, Noske GD, Gawriljuk VO, Oliveira KIZ, Godoy AS, Mesquita NC de MR, Oliva G. High-throughput antiviral assays to screen for inhibitors of Zika virus replication [Internet]. Journal of Visualized Experiments - JOVE. 2021 ; 176 e62422-1-e62422-11.[citado 2025 out. 07 ] Available from: https://doi.org/10.3791/62422
Trabalho de evento-resumo
Structural insights of the SARS-CoV-2 main protease maturation process in the first user experiment of SIRIUS (2021)
Noske, Gabriela Dias; Nakamura, Aline Minali; Oliveira, Victor Gawriljuk Ferraro; Fernandes, Rafaela Sachetto; Lima, G. M. A.; Rosa, Higor Vinicius Dias; Pereira, Humberto d'Muniz ; Zeri, A. C. M.; Nascimento, A. F. Z.; Freire, Marjorie Caroline Liberato Cavalcanti; Fearon, D.; Douangamath, A.; von Delft, F.; Oliva, Glaucius ; Godoy, Andre Schutzer de
Source: Programação das apresentações. Conference titles: Reunião da Associação Brasileira de Cristalografia. Unidade: IFSC
Subjects: COVID-19, CORONAVIRUS, ANTIVIRAIS, PLANEJAMENTO DE FÁRMACOS, PROTEÍNAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NOSKE, Gabriela Dias et al. Structural insights of the SARS-CoV-2 main protease maturation process in the first user experiment of SIRIUS. 2021, Anais.. Campinas: Associação Brasileira de Cristalografia - ABCr, 2021. Disponível em: https://www.eventweb.com.br/xxvabcr/specific-files/manuscripts/xxvabcr/resumo-650.pdf. Acesso em: 07 out. 2025.
APA
Noske, G. D., Nakamura, A. M., Oliveira, V. G. F., Fernandes, R. S., Lima, G. M. A., Rosa, H. V. D., et al. (2021). Structural insights of the SARS-CoV-2 main protease maturation process in the first user experiment of SIRIUS. In Programação das apresentações. Campinas: Associação Brasileira de Cristalografia - ABCr. Recuperado de https://www.eventweb.com.br/xxvabcr/specific-files/manuscripts/xxvabcr/resumo-650.pdf
NLM
Noske GD, Nakamura AM, Oliveira VGF, Fernandes RS, Lima GMA, Rosa HVD, Pereira H d'M, Zeri ACM, Nascimento AFZ, Freire MCLC, Fearon D, Douangamath A, von Delft F, Oliva G, Godoy AS de. Structural insights of the SARS-CoV-2 main protease maturation process in the first user experiment of SIRIUS [Internet]. Programação das apresentações. 2021 ;[citado 2025 out. 07 ] Available from: https://www.eventweb.com.br/xxvabcr/specific-files/manuscripts/xxvabcr/resumo-650.pdf
Vancouver
Noske GD, Nakamura AM, Oliveira VGF, Fernandes RS, Lima GMA, Rosa HVD, Pereira H d'M, Zeri ACM, Nascimento AFZ, Freire MCLC, Fearon D, Douangamath A, von Delft F, Oliva G, Godoy AS de. Structural insights of the SARS-CoV-2 main protease maturation process in the first user experiment of SIRIUS [Internet]. Programação das apresentações. 2021 ;[citado 2025 out. 07 ] Available from: https://www.eventweb.com.br/xxvabcr/specific-files/manuscripts/xxvabcr/resumo-650.pdf
Trabalho de evento-resumo
Structural basis for SARS-CoV-2 main protease maturation process (2021)
Noske, Gabriela Dias; Nakamura, Aline Minali; Oliveira, Victor Gawriljuk Ferraro; Fernandes, Rafaela Sachetto; Lima, G. M. A.; Rosa, Higor Vinicius Dias; Pereira, Humberto d'Muniz ; Zeri, A. C. M.; Nascimento, A. F. Z.; Freire, Marjorie Caroline Liberato Cavalcanti; Fearon, D.; Douangamath, A.; von Delft, F.; Godoy, Andre Schutzer de ; Oliva, Glaucius
Source: Programação das apresentações. Conference titles: Reunião da Associação Brasileira de Cristalografia. Unidade: IFSC
Subjects: COVID-19, CORONAVIRUS, ANTIVIRAIS, PLANEJAMENTO DE FÁRMACOS, PROTEÍNAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NOSKE, Gabriela Dias et al. Structural basis for SARS-CoV-2 main protease maturation process. 2021, Anais.. Campinas: Associação Brasileira de Cristalografia - ABCr, 2021. Disponível em: https://www.eventweb.com.br/xxvabcr/specific-files/manuscripts/xxvabcr/resumo-626.pdf. Acesso em: 07 out. 2025.
APA
Noske, G. D., Nakamura, A. M., Oliveira, V. G. F., Fernandes, R. S., Lima, G. M. A., Rosa, H. V. D., et al. (2021). Structural basis for SARS-CoV-2 main protease maturation process. In Programação das apresentações. Campinas: Associação Brasileira de Cristalografia - ABCr. Recuperado de https://www.eventweb.com.br/xxvabcr/specific-files/manuscripts/xxvabcr/resumo-626.pdf
NLM
Noske GD, Nakamura AM, Oliveira VGF, Fernandes RS, Lima GMA, Rosa HVD, Pereira H d'M, Zeri ACM, Nascimento AFZ, Freire MCLC, Fearon D, Douangamath A, von Delft F, Godoy AS de, Oliva G. Structural basis for SARS-CoV-2 main protease maturation process [Internet]. Programação das apresentações. 2021 ;[citado 2025 out. 07 ] Available from: https://www.eventweb.com.br/xxvabcr/specific-files/manuscripts/xxvabcr/resumo-626.pdf
Vancouver
Noske GD, Nakamura AM, Oliveira VGF, Fernandes RS, Lima GMA, Rosa HVD, Pereira H d'M, Zeri ACM, Nascimento AFZ, Freire MCLC, Fearon D, Douangamath A, von Delft F, Godoy AS de, Oliva G. Structural basis for SARS-CoV-2 main protease maturation process [Internet]. Programação das apresentações. 2021 ;[citado 2025 out. 07 ] Available from: https://www.eventweb.com.br/xxvabcr/specific-files/manuscripts/xxvabcr/resumo-626.pdf

USP Schools

ReP

Filtros

Departament

Authors

USP affiliated authors

Subjects

Source title

Grupo de pesquisa

Funding Agencies

Non normalized affiliation

Countries of institutions of collaboration